Skip to main content
OpenTrials

Clinical trial condition

Eosinophilia

Explore clinical trials studying Eosinophilia. Study availability and eligibility vary by location and protocol.

264 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Eosinophilia trial results

Completed

Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients

NCT02555371

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site New Haven, Connecticut, United States
View all 73 locations
View Trial Details
Completed

Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children

NCT02377427

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Medford, Oregon, United States
  • GSK Investigational Site Madison, Wisconsin, United States
View all 16 locations
View Trial Details
Completed

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

NCT02135692

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site Denver, Colorado, United States
View all 114 locations
View Trial Details
Completed

Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients

NCT02654145

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Roseville, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 53 locations
View Trial Details
Completed

Study of Mepolizumab Safety Syringe in Asthmatics

NCT03021304

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
  • GSK Investigational Site Orangeburg, South Carolina, United States
View all 15 locations
View Trial Details

Related conditions